Annual D&A
$57.37 M
+$1.97 M+3.55%
31 December 2023
Summary:
Bioventus annual depreciation & amortization is currently $57.37 million, with the most recent change of +$1.97 million (+3.55%) on 31 December 2023. During the last 3 years, it has risen by +$28.72 million (+100.28%). BVS annual D&A is now at all-time high.BVS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$12.28 M
-$815.00 K-6.23%
28 September 2024
Summary:
Bioventus quarterly depreciation & amortization is currently $12.28 million, with the most recent change of -$815.00 thousand (-6.23%) on 28 September 2024. Over the past year, it has dropped by -$1.55 million (-11.22%). BVS quarterly D&A is now -27.55% below its all-time high of $16.94 million, reached on 31 December 2022.BVS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$49.62 M
-$1.55 M-3.03%
28 September 2024
Summary:
Bioventus TTM depreciation & amortization is currently $49.62 million, with the most recent change of -$1.55 million (-3.03%) on 28 September 2024. Over the past year, it has dropped by -$12.23 million (-19.77%). BVS TTM D&A is now -19.77% below its all-time high of $61.84 million, reached on 30 September 2023.BVS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVS Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +3.5% | -11.2% | -19.8% |
3 y3 years | +100.3% | +44.0% | +65.2% |
5 y5 years | +96.2% | +34.3% | +443.0% |
BVS Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +100.3% | -27.6% | +44.0% | -19.8% | +65.2% |
5 y | 5 years | at high | +100.3% | -27.6% | +79.1% | -19.8% | +582.9% |
alltime | all time | at high | +134.5% | -27.6% | +79.1% | -19.8% | +582.9% |
Bioventus Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $12.28 M(-6.2%) | $49.62 M(-3.0%) |
June 2024 | - | $13.09 M(+11.1%) | $51.17 M(-2.9%) |
Mar 2024 | - | $11.79 M(-5.5%) | $52.68 M(-8.2%) |
Dec 2023 | $57.37 M(+3.6%) | $12.46 M(-9.9%) | $57.37 M(-7.2%) |
Sept 2023 | - | $13.83 M(-5.3%) | $61.84 M(+0.4%) |
June 2023 | - | $14.60 M(-11.4%) | $61.61 M(+3.7%) |
Mar 2023 | - | $16.47 M(-2.8%) | $59.39 M(+7.2%) |
Dec 2022 | $55.40 M(+58.8%) | $16.94 M(+24.6%) | $55.40 M(+10.5%) |
Sept 2022 | - | $13.59 M(+9.8%) | $50.15 M(+11.3%) |
June 2022 | - | $12.38 M(-0.8%) | $45.08 M(+12.2%) |
Mar 2022 | - | $12.48 M(+6.7%) | $40.17 M(+15.2%) |
Dec 2021 | $34.88 M | $11.69 M(+37.2%) | $34.88 M(+16.1%) |
Sept 2021 | - | $8.52 M(+13.9%) | $30.04 M(+4.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2021 | - | $7.48 M(+4.1%) | $28.79 M(+0.8%) |
Mar 2021 | - | $7.18 M(+4.8%) | $28.56 M(-0.3%) |
Dec 2020 | $28.64 M(-5.5%) | $6.85 M(-5.8%) | $28.64 M(+31.5%) |
Sept 2020 | - | $7.28 M(+0.4%) | $21.79 M(+50.1%) |
June 2020 | - | $7.25 M(-0.2%) | $14.51 M(+99.8%) |
Mar 2020 | - | $7.26 M(-20.5%) | $7.26 M(-20.5%) |
Dec 2019 | $30.32 M(+3.7%) | - | - |
Dec 2018 | $29.24 M(-11.6%) | - | - |
Mar 2016 | - | $9.14 M(+8.9%) | $9.14 M(+8.9%) |
Dec 2015 | $33.08 M(+14.8%) | - | - |
Mar 2015 | - | $8.39 M | $8.39 M |
Dec 2014 | $28.82 M(+17.8%) | - | - |
Dec 2013 | $24.46 M | - | - |
FAQ
- What is Bioventus annual depreciation & amortization?
- What is the all time high annual D&A for Bioventus?
- What is Bioventus annual D&A year-on-year change?
- What is Bioventus quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Bioventus?
- What is Bioventus quarterly D&A year-on-year change?
- What is Bioventus TTM depreciation & amortization?
- What is the all time high TTM D&A for Bioventus?
- What is Bioventus TTM D&A year-on-year change?
What is Bioventus annual depreciation & amortization?
The current annual D&A of BVS is $57.37 M
What is the all time high annual D&A for Bioventus?
Bioventus all-time high annual depreciation & amortization is $57.37 M
What is Bioventus annual D&A year-on-year change?
Over the past year, BVS annual depreciation & amortization has changed by +$1.97 M (+3.55%)
What is Bioventus quarterly depreciation & amortization?
The current quarterly D&A of BVS is $12.28 M
What is the all time high quarterly D&A for Bioventus?
Bioventus all-time high quarterly depreciation & amortization is $16.94 M
What is Bioventus quarterly D&A year-on-year change?
Over the past year, BVS quarterly depreciation & amortization has changed by -$1.55 M (-11.22%)
What is Bioventus TTM depreciation & amortization?
The current TTM D&A of BVS is $49.62 M
What is the all time high TTM D&A for Bioventus?
Bioventus all-time high TTM depreciation & amortization is $61.84 M
What is Bioventus TTM D&A year-on-year change?
Over the past year, BVS TTM depreciation & amortization has changed by -$12.23 M (-19.77%)